Lifesprout

About:

LifeSprout offers revolutionary products for soft tissue replacement and regeneration

Website: https://www.lifesproutbio.com

Top Investors: Nexus Capital Management, TEDCO, Redmile Group, AngelMD, Medytox

Description:

LifeSprout is developing the next generation of synthetic soft tissue substitutes for aesthetic and reconstructive medicine. They offer revolutionary products for aesthetic and regenerative medicine. They have created a platform that looks and behaves like the body’s own tissues. The company is turning this into a suite of products for millions of patients each year with soft tissue losses from aging, cancer, and metabolic disease.

Total Funding Amount:

$35.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)lifesproutbio.com

Founders:

Hai-Quan Mao, Justin Sacks, Russell Martin, Sashank Reddy

Number of Employees:

1-10

Last Funding Date:

2020-04-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai